|
| 32017048 | Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. | Clin Pharmacol Ther | 2020 |
| 30102605 | Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) Approach. | Appl Immunohistochem Mol Morphol | 2019 |
| 29338703 | Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. | BMC Cancer | 2018 |
| 29158372 | Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing. | Oncologist | 2018 |
| 27861902 | The molecular basis of breast cancer pathological phenotypes. | J Pathol | 2017 |
| 28381416 | A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. | Clin Cancer Res | 2017 |
| 28187516 | Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium. | Clin Pharmacol Ther | 2017 |
| 26371432 | Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing. | Appl Immunohistochem Mol Morphol | 2016 |
| 26507436 | Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease. | Clin Exp Metastasis | 2016 |
| 26076459 | Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC. | PLoS One | 2015 |
| 24628946 | Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. | Pigment Cell Melanoma Res | 2014 |
| 22820657 | Tissue pattern recognition error rates and tumor heterogeneity in gastric cancer. | Appl Immunohistochem Mol Morphol | 2013 |
| 24132288 | Criteria for the use of omics-based predictors in clinical trials. | Nature | 2013 |
| 24228635 | Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. | BMC Med | 2013 |
| 22801299 | Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue. | Lab Invest | 2012 |
| 20668451 | Diverse somatic mutation patterns and pathway alterations in human cancers. | Nature | 2010 |
| 19460940 | A tumor sorting protocol that enables enrichment of pancreatic adenocarcinoma cells and facilitation of genetic analyses. | J Mol Diagn | 2009 |
| 19861557 | EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. | J Clin Pathol | 2009 |
| 18281673 | Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. | J Clin Oncol | 2008 |
| 17704782 | Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detection. | Nat Methods | 2007 |
| 17947484 | Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer. | Clin Cancer Res | 2007 |
| 16896006 | Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. | J Clin Oncol | 2006 |
| 15753462 | Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer. | J Clin Oncol | 2005 |
| 16361555 | Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. | Clin Cancer Res | 2005 |
| 16043828 | Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. | J Clin Oncol | 2005 |
| 15956649 | Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. | J Natl Cancer Inst | 2005 |
| 15073007 | GEPIS--quantitative gene expression profiling in normal and cancer tissues. | Bioinformatics | 2004 |
| 12538818 | Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction. | J Pharmacol Exp Ther | 2003 |
| 11980648 | Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. | Cancer Res | 2002 |
| 11590242 | Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. | J Cell Sci | 2001 |
| 11358845 | Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. | Cancer Res | 2001 |
| 11103779 | Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. | Cancer Res | 2000 |
| 9461492 | Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins. | Biochem J | 1998 |
| 9285598 | Histopathology of arteriovenous malformations after gamma knife radiosurgery. | J Neurosurg | 1997 |
| 8558140 | Alzheimer's disease in a case of cortical basal ganglionic degeneration with severe dementia. | J Neurol Neurosurg Psychiatry | 1996 |
| 8559373 | Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature. | Neurology | 1996 |
| 7808975 | Two-year-old boy with Proteus syndrome and fatal pulmonary thromboembolism. | Pediatr Pathol | 1994 |
| 8080046 | Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. | Am J Pathol | 1994 |
| 8279337 | Pleomorphic xanthoastrocytoma, a distinctive astroglial tumor: neuroradiologic and pathologic features. | AJNR Am J Neuroradiol | 1993 |
| 1651165 | Calcium promotes the accumulation of polyphosphoinositides in intact and permeabilized bovine adrenal chromaffin cells. | Cell Mol Neurobiol | 1991 |
| 1953641 | Regulation of the formation of inositol phosphates by calcium, guanine nucleotides and ATP in digitonin-permeabilized bovine adrenal chromaffin cells. | Biochem J | 1991 |
| 2160809 | Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. | Biochem J | 1990 |
| 2784433 | MgATP-independent and MgATP-dependent exocytosis. Evidence that MgATP primes adrenal chromaffin cells to undergo exocytosis. | J Biol Chem | 1989 |
| 2471303 | Intracellular Ca2+ activates phospholipase C. | Trends Neurosci | 1988 |
| 3668543 | Cholinergic stimulation of inositol phosphate formation in bovine adrenal chromaffin cells: distinct nicotinic and muscarinic mechanisms. | J Neurochem | 1987 |